MARKET

PFE

PFE

Pfizer
NYSE
27.30
+0.14
+0.52%
After Hours: 27.21 -0.09 -0.33% 19:50 03/11 EDT
OPEN
27.20
PREV CLOSE
27.16
HIGH
27.41
LOW
27.00
VOLUME
40.56M
TURNOVER
--
52 WEEK HIGH
27.94
52 WEEK LOW
19.50
MARKET CAP
155.24B
P/E (TTM)
20.07
1D
5D
1M
3M
1Y
5Y
1D
Moderna, BioNTech rise as vaccine advisory panel backs off mRNA vaccine threat
Seeking Alpha · 5h ago
Mixed options sentiment in Pfizer with shares down 0.39%
TipRanks · 6h ago
Pfizer Advances Next-Gen Pneumococcal Vaccine With Completed Phase 2 Toddler Study
TipRanks · 8h ago
Regeneron: Fairly Valued Now After A Stellar Upswing
Seeking Alpha · 11h ago
Wells Fargo Sticks to Its Hold Rating for Pfizer (PFE)
TipRanks · 14h ago
Sanofi, Regeneron's Eczema Drug Might Face Competition From Pfizer -- Market Talk
Dow Jones · 14h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)
TipRanks · 14h ago
Pfizer: Cheap For A Reason
Seeking Alpha · 16h ago
More
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.